| Authors: |
Weekes A; Freelance consultant, Melbourne, VIC, Australia.; FacioBiotherapies, Non-executive Director, Melbourne, VIC, Australia., Britland M; Medwise Consulting, Sydney, NSW, Australia.; School of Public Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia., Saha C; Abbvie Pty Ltd, Sydney, NSW, Australia., McErlane S; Amicus Therapeutics Pty Ltd, Sydney, NSW, Australia., Ansari N; Amgen Australia Pty Ltd, Sydney, NSW, Australia., Thurley D; Sydney Health Executive Education, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.; Axis HealthCo., Sydney, NSW, Australia., Elegant V; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.; Chief Medical Officer, QBiotics, Brisbane, QLD, Australia., Chisholm O; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia. orin.chisholm@sydney.edu.au.; Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia. orin.chisholm@sydney.edu.au. |
